Randomized controlled trial of interferon alpha-2b in hepatitis C virus related cirrhosis.

被引：0
|
作者：
Valla, D
Chevallier, M
Payen, JL
Marcellin, P
Parlier, D
Trepo, C
Couzigou, P
Degos, F
Boucher, E
Miguet, J
Gauthier, A
Lemonnier, C
Opolon, P
机构：
[1] GRP HOSP PITIE SALPETRIERE,F-75634 PARIS,FRANCE
[2] HOP BEAUJON,CLICHY,FRANCE
[3] PURPAN,TOULOUSE,FRANCE
[4] HOP HOTEL DIEU,LYON,FRANCE
[5] HAUT LEVEQUE,BORDEAUX,FRANCE
[6] HOP PONTCHAILLOU,RENNES,FRANCE
[7] HOP JEAN MINJOZ,F-25030 BESANCON,FRANCE
[8] HOP CONCEPTION,MARSEILLE,FRANCE
[9] INST PASTEUR,LYON,FRANCE
[10] SCHERING PLOUGH FRANCE,LEVALLOIS PERRET,FRANCE
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [1] IS INTERFERON ALPHA-2B EFFECTIVE ON CRYOGLOBULINEMIA RELATED TO HEPATITIS-C VIRUS
    TAILLAN, B
    FERRARI, E
    PESCE, A
    GARNIER, G
    VINTI, H
    FUZIBET, JG
    DUJARDIN, P
    [J]. CLINICAL RHEUMATOLOGY, 1992, 11 (04) : 579 - 579
  • [2] A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus
    Ikeda, K
    Kumada, H
    Saitoh, S
    Suzuki, Y
    Kobayashi, M
    Tsubota, A
    Koida, I
    Fukuda, M
    Arase, Y
    Chayama, K
    Murashima, N
    Tango, T
    [J]. JOURNAL OF HEPATOLOGY, 1998, 28 (05) : 910 - 911
  • [3] Treatment of hepatitis c virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
    Valla, DC
    Chevallier, M
    Marcellin, P
    Payen, JL
    Trepo, C
    Fonck, M
    Bourliere, M
    Boucher, E
    Miguet, JP
    Parlier, D
    Lemonnier, C
    Opolon, P
    [J]. HEPATOLOGY, 1999, 29 (06) : 1870 - 1875
  • [4] Interferon alpha-2b treatment of HIV negative hemophiliacs with chronic hepatitis C: A multicenter controlled, randomized open trial
    Santagostino, E
    Rumi, MG
    Gringeri, A
    Morfini, M
    Tagariello, G
    Ciavarella, N
    Mazzucconi, MG
    Pontisso, P
    Tagger, A
    Colombo, M
    Mannucci, PM
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PD666 - PD666
  • [5] Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C
    Ishibashi, Y
    Takeda, K
    Tsukidate, N
    Miyazaki, H
    Ohira, K
    Dosaka-Akita, H
    Nishimura, M
    [J]. HEPATOLOGY RESEARCH, 2005, 32 (04) : 218 - 223
  • [6] A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
    Younossi, ZM
    Mullen, KD
    Zakko, W
    Hodnick, S
    Brand, E
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Boparai, N
    Gramlich, T
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 128 - 133
  • [7] Randomized controlled trial of interferon therapy as chemoprevention of hepatocellular carcinoma (HCC) in hepatitits C virus (HCV) related cirrhosis.
    Benvegnu, L
    Gios, M
    Carrara, G
    Belussi, F
    Antona, C
    Felder, M
    Fornaciari, G
    Marin, R
    Dona, G
    Casarin, P
    Pancotti, D
    Cavinato, F
    Alberti, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 386A - 386A
  • [8] A randomized controlled trial of pegylated-interferon alpha-2b plus ribavirin vs interferon
    Pol, S
    Perronne, C
    Carrat, F
    Banisadr, F
    Morand, P
    Lunel, F
    Rosenthal, E
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 32 - 32
  • [9] MULTICENTER RANDOMIZED TRIAL WITH RECOMBINANT INTERFERON ALPHA-2B (IFN) IN THE TREATMENT OF CHRONIC HEPATITIS-C
    SANGIOVANNI, A
    SPINZI, GC
    BISSOLI, F
    COLOMBO, E
    RAINER, H
    COLLI, A
    CASIRAGHI, A
    FOSSATI, M
    ROCCA, F
    MINOLI, G
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A984 - A984
  • [10] Treatment with interferon alpha-2b in haemophiliac patients infected with hepatitis C virus
    Quintana, M
    Canales, M
    Jimenez-Yuste, V
    Villar, A
    Morado, M
    Gago, J
    Sanjurjo, MJ
    Magallon, M
    Hernandez-Navarro, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 789 - 790
12345